Water: Clinical Trials

40 trials of Water, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 3 unknown, 2 not yet recruiting, 2 recruiting. 40 Phase 3, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 340Completed 31, Unknown 3, Not yet recruiting 2, Recruiting 2, Terminated 1, Withdrawn 1
Phase 212Completed 8, Not yet recruiting 2, Recruiting 1, Unknown 1

Follow Water: new trials by email Literature Review of Water trials Research Report on Water

Trials (filtered) newest first · largest first

All 40 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases
1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water, 1.0% IP-001 for Injection, a 1 mg/mL solution of IP-001 in water., Microwave (thermal) tumor ablation - Colorectal Cancer (CRC), Colon Cancer Liver Metastases
Phase 2 / Phase 3Not yet recruitingImmunophotonics, Inc.7172026-05-012026-01-07
Postpartum 8-aminoquinoline Breast Milk Study
Daily primaquine (0.5 mg/kg per day) for 14 days given with food food and water, Daily primaquine 1 mg/kg per day for 7 days given with food and water, Single-dose tafenoquine given with food and water to prevent gastrointestinal discomfort - Drug Pharmacokinetics in Healthy Volunteers
Phase 2 / Phase 3Not yet recruitingCurtin University602026-04-012026-03-18
Efficacy Testing of a Multi-Level Family Planning Intervention
Family Planning Intervention, Water, Sanitation, and Hygiene (WASH) Intervention - Unintended Pregnancy, Family Planning
Phase 2 / Phase 3RecruitingBoston College14642025-06-122026-03-23
Biperiden Trial for Epilepsy Prevention
Biperiden, Placebo - Brain Injury Traumatic Moderate, Brain Injury Traumatic Severe
Phase 3RecruitingHospital Sirio-Libanes3122023-01-102024-03-26
High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda
Ascorbic Acid 500Mg/Ml Inj, Dextrose in Water - Sepsis
Phase 3WithdrawnVirginia Commonwealth University2022-10-012022-10-18
Suaahara Impact Evaluation: End-line Survey
Health and family planning, Nutrition, Agriculture and homestead food production - Nutritional Stunting, Feeding Behavior
Phase 3CompletedUniversity of South Carolina24802022-06-172023-01-06
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
Ethanol, Water Distilled - Clinical Infection, Outcome
Phase 3CompletedAli Amoushahi1502021-09-022022-04-25
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)
Trilaciclib, Placebo, Gemcitabine - TNBC - Triple-Negative Breast Cancer, Breast Cancer
Phase 3CompletedG1 Therapeutics, Inc.1942021-05-142024-08-01
Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders
Non invasive VN stimulation (nVNS), Oxygen (15-O) Water, Sham Stimulation - Substance-Related Disorders, Substance Use Disorders
Phase 3CompletedEmory University202020-11-132023-09-13
Efficacy of Zinc L-Carnosine Mouth Rinse
Zinc L-Carnosine, Chlorhexidine, Water - Periodontal Index, Pain
Phase 3UnknownUniversity of Milan752020-06-012020-06-18
Surgical Idiopathic Intracranial Hypertension Treatment Trial
Acetazolamide, Optic Nerve Sheath Fenestration, Ventriculoperitoneal CSF Shunting - Idiopathic Intracranial Hypertension
Phase 3TerminatedJaeb Center for Health Research72019-02-062022-06-16
Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy
Simethicone Solution, Water - Colonoscopy
Phase 3CompletedUniversity of Nevada, Reno2502018-01-092018-12-12
Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
Clarithromycin, Water for injection - Sepsis, Pneumonia
Phase 3CompletedHellenic Institute for the Study of Sepsis1102017-12-152020-12-22
Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery
Cytoflavin® solution, Cytoflavin® enteric-coated tablet, Placebo solution - Cognitive Dysfunction
Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company2002017-06-022023-01-31
The Fluid Therapy Strategy of the Non-dehydrated Patients With Acute Ischemic Stroke.
water - Stroke, Dehydration
Phase 2 / Phase 3UnknownChang Gung Memorial Hospital2502016-01-012017-06-23
Stopping Cavities Study: Diammine Silver Fluoride
38% diammine silver fluoride, Water - Dental Caries
Phase 3CompletedAdvantage Dental Services, LLC662016-01-012020-01-23
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
Water, sanitation, and hygiene (WASH) intervention, Standard of care WASH intervention, Azithromycin - Trachoma
Phase 3CompletedUniversity of California, San Francisco476052015-12-052026-06-04
Small Volume Simethicone Before Gastroscopy: Any Benefit?
Simethicone, Water - Lesion of Stomach
Phase 2 / Phase 3CompletedChangi General Hospital542015-08-012016-03-15
Pre-procedural Mouthwash in Reducing Bacteria in Dental Aerosols
Dental prophylaxis, Mouthwash CPC+Zn+F, Mouthwash CHX - Chronic Periodontitis
Phase 3CompletedUniversity of Guarulhos602015-02-012020-06-04
A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis
IV N-acetylcysteine (NAC), Water - Drug-Induced Liver Injury
Phase 2 / Phase 3CompletedUniversity of Cape Town1022014-05-012019-02-19

Showing 20 of 40. Sign in to see all of them.

Conditions studied

Pain (4)  ·  Breast Neoplasms (3)  ·  Dental Caries (3)  ·  Neoplasm Metastasis (2)  ·  Neoplasms (2)  ·  Sepsis (2)  ·  Agammaglobulinemia (1)  ·  Agnosia (1)  ·  Brain Injuries (1)  ·  Breast Feeding (1)  ·  COVID-19 (1)  ·  Cancer Pain (1)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Chronic Periodontitis (1)  ·  Cognitive Dysfunction (1)

Sponsors

The University of Hong Kong (2)  ·  Tranzyme, Inc. (2)  ·  Advantage Dental Services, LLC (1)  ·  Ali Amoushahi (1)  ·  Boston College (1)  ·  British Columbia Cancer Agency (1)  ·  Carmel Medical Center (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Chang Gung Memorial Hospital (1)  ·  Changi General Hospital (1)  ·  Colgate Palmolive (1)  ·  Curtin University (1)  ·  Emory University (1)  ·  Federal University of São Paulo (1)  ·  G1 Therapeutics, Inc. (1)

Countries

United States (15)  ·  Canada (6)  ·  France (4)  ·  Italy (4)  ·  Bulgaria (3)  ·  China (3)  ·  Poland (3)  ·  Romania (3)  ·  Russia (3)  ·  United Kingdom (3)  ·  Czechia (2)  ·  Hungary (2)  ·  Ukraine (2)  ·  Australia (1)  ·  Belgium (1)

Top investigators

Edward CM Lo, BDS, PhD (2)  ·  Anna Taddio, PhD (1)  ·  Anne M. Lynn, MD (1)  ·  Apostolos Armaganidis, MD, PhD (1)  ·  Aurimery G Chermont (1)  ·  Brioni Moore, PhD (1)  ·  Chiara Occhipinti, Professor (1)  ·  Dennis A Hopkinson, MD (1)  ·  Diane M Beatty, PhD (1)  ·  Dionna M Wittberg, MPH (1)  ·  Edward A Frongillo, PhD (1)  ·  Elham Moazam, Researcher (1)  ·  Eliana Garzon, MD, PhD (1)  ·  Elizabeth A Mittendorf, MD,FACS (1)

Results publications

PMID 23739196, PMID 10933646, PMID 15316186, PMID 17456651, PMID 18444850, PMID 19948613, PMID 20042524, PMID 20354090, PMID 20610825, PMID 21199130, PMID 22564837, PMID 23055587, PMID 24024983, PMID 24292991, PMID 24685786, PMID 24768671, PMID 24807329, PMID 24992844, PMID 26215946, PMID 26338107, PMID 26478974, PMID 27044546, PMID 27956393, PMID 28455250, PMID 30938645, PMID 31036542, PMID 33619183, PMID 34919861, PMID 35717241, PMID 36041704, PMID 36084082, PMID 36135712, PMID 38134305, PMID 38342986, PMID 38991011, PMID 40548916, PMID 41314021, PMID 41548574, PMID 7499664

NIH funding

2025 (1), P01DK068055 (1), R01HD113806 (1), U01DK072146 (1), U10EY023939 (1), U10EY025990 (1), UG3DA048502 (1)